MODIFICACIONES CRISTALINAS DE PIRACLOSTROBINA Y PROCEDIMIENTO PARA PREPARARLAS

    公开(公告)号:PE00902007A1

    公开(公告)日:2007-02-09

    申请号:PE0006812006

    申请日:2006-06-16

    Applicant: BASF AG

    CPC classification number: A01N47/24 C07D231/22 A01N25/04 A01N25/02 A01N2300/00

    Abstract: SE REFIERE A UNA MODIFICACION CRISTALINA IV, LA CUAL EN UN DIFRACTOGRAMA DE POLVO DE RAYOS X A 25°C DEMUESTRA POR LO MENOS TRES DE LOS REFLEJOS SIGUIENTES: d=6,02± 0,01 Å, d=4,78± 0,01 Å, d=4,01± 0,01 Å, d=3,55± 0,01 Å Y d=3,01± 0,01 Å; TENIENDO UN PUNTO DE FUSION ENTRE 62°C Y 72°C, Y UN CONTENIDO DE PIRACLOSTROBINA POR LO MENOS DE 98% EN PESO. UNA MODIFICACION CRISTALINA II, LA CUAL EN UN DIFRACTOGRAMA DE POLVO DE RAYOS X A 25°C DEMUESTRA POR LO MENOS CUATRO DE LOS REFLEJOS SIGUIENTES: d=5,93± 0,01 Å, d=5,82± 0,01 Å, d=4,89± 0,01 Å, d=4,78± 0,01 Å Y d=4,71± 0,01 Å, d=3,97± 0,01 Å, d=3,89± 0,01 Å, d=3,77± 0,01 Å; d=3,75± 0,01 Å, d=3,57± 0,01 Å Y d=3,43± 0,01 Å; TENIENDO UN PUNTO DE FUSION ENTRE 57°C Y 58°C, Y UN CONTENIDO DE PIRACLOSTROBINA POR LO MENOS DE 98% EN PESO. DICHAS MODIFICACIONES SE USAN PARA CONTROLAR HONGOS FITOPATOGENOS. EL PROCEDIMIENTO PARA PREPARALAS INCLUYE: a) PREPARAR UNA SUSPENSION DE O DISOLVER UNA FORMA DE PIRACLOSTROBINA DIFERENTE DE LA MODIFICACION IV, A UNA TEMPERATURA SUPERIOR A 50°C, EN UN SOLVENTE ORGANICO O MEZCLA SOLVENTE QUE COMPRENDE POR LO MENOS 70% EN VOLUMEN DE POR LO MENOS UN SOLVENTE ORGANICO TOTALMENTE MISCIBLE EN AGUA (ALCANOLES C1-C4, ACETONA Y BUTANONA) Y SI FUERA APROPIADO HASTA 30% EN VOLUMEN DE AGUA; Y, b) EFECTUAR LA CRISTALIZACION DE PIRACLOSTROBINA DURANTE POR LO MENOS 10 HORAS, Y/O EN PRESENCIA DE NUCLEOS CRISTALINOS DE MODIFICACION IV, ENFRIANDO LA SOLUCION O AGREGANDO AGUA A LA SOLUCION DE PIRACLOSTROBINA

    NANOPARTICULATE ACTIVE SUBSTANCE FORMULATIONS

    公开(公告)号:CA2543553A1

    公开(公告)日:2005-05-26

    申请号:CA2543553

    申请日:2004-10-19

    Applicant: BASF AG

    Abstract: New active agent formulations contain active agent(s) (A); random radical copolymer(s) (B), derived from sulfoalkyl (meth)acrylate or N-sulfoalkyl-(meth)acrylamide monomer(s) (I) (and/or their salts), (meth)acrylate ester or N-substituted (meth)acrylamide monomer(s) (II) and optionally further monomers; and optionally further additives (C). New active agent formulations contain active agent(s) (A); random radical copolymer(s) (B), derived from olefinically unsaturated sulfonic acid(s) of formula (I) (and/or their salts), monomer(s) of formula H 2C=C(R 4>)-CO-YR 6> (II) and optionally further monomers; and optionally further additives (C). n : 0-10; X, Y : O or NR 5>; R 1>, R 4>H or Me; R 2>, R 3>H or 1-6C alkyl; R 5>, R 6>H, alkyl, aryl, alkylaryl, alkoxyalkyl, aryloxyalkyl, alkoxyaryl, hydroxyalkyl, (di)alkylaminoalkyl, (di)arylaminoalkyl, alkylarylaminoalkyl or alkylarylaminoaryl (where aryl groups are optionally substituted). Independent claims are included for: (1) the preparation of aqueous dispersions, by contacting the formulations with aqueous systems (optionally in presence of additives) and dispersion conventionally; (2) the preparation of the formulations, by dissolving (A) - (C) and optionally further additives in an organic solvent (or dissolving the components separately in organic solvents then mixing the solutions), then conventionally removing the solvent; and (3) an alternative preparation of the formulations, by forming an aqueous solution of (B); dissolving (A), (C) (if present) and optionally further additives in water-miscible organic solvent(s); mixing the solutions; applying energy to form a dispersion; and conventionally removing the solvent. [Image].

    Nanoparticulate active substance formulations

    公开(公告)号:AU2004289034A1

    公开(公告)日:2005-05-26

    申请号:AU2004289034

    申请日:2004-10-19

    Applicant: BASF AG

    Abstract: New active agent formulations contain active agent(s) (A); random radical copolymer(s) (B), derived from sulfoalkyl (meth)acrylate or N-sulfoalkyl-(meth)acrylamide monomer(s) (I) (and/or their salts), (meth)acrylate ester or N-substituted (meth)acrylamide monomer(s) (II) and optionally further monomers; and optionally further additives (C). New active agent formulations contain active agent(s) (A); random radical copolymer(s) (B), derived from olefinically unsaturated sulfonic acid(s) of formula (I) (and/or their salts), monomer(s) of formula H 2C=C(R 4>)-CO-YR 6> (II) and optionally further monomers; and optionally further additives (C). n : 0-10; X, Y : O or NR 5>; R 1>, R 4>H or Me; R 2>, R 3>H or 1-6C alkyl; R 5>, R 6>H, alkyl, aryl, alkylaryl, alkoxyalkyl, aryloxyalkyl, alkoxyaryl, hydroxyalkyl, (di)alkylaminoalkyl, (di)arylaminoalkyl, alkylarylaminoalkyl or alkylarylaminoaryl (where aryl groups are optionally substituted). Independent claims are included for: (1) the preparation of aqueous dispersions, by contacting the formulations with aqueous systems (optionally in presence of additives) and dispersion conventionally; (2) the preparation of the formulations, by dissolving (A) - (C) and optionally further additives in an organic solvent (or dissolving the components separately in organic solvents then mixing the solutions), then conventionally removing the solvent; and (3) an alternative preparation of the formulations, by forming an aqueous solution of (B); dissolving (A), (C) (if present) and optionally further additives in water-miscible organic solvent(s); mixing the solutions; applying energy to form a dispersion; and conventionally removing the solvent. [Image].

    28.
    发明专利
    未知

    公开(公告)号:BRPI0612246A2

    公开(公告)日:2011-01-04

    申请号:BRPI0612246

    申请日:2006-06-19

    Applicant: BASF AG

    Abstract: Crystalline modification IV of pyraclostrobin (A) exhibits at least three reflexes in an X-ray powder diffractogram at 25[deg]C, where the reflections (d) are 6.02 +- 0.01 Å, 4.78 +- 0.01 Å, 4.01 +- 0.01 Å, 3.55 +- 0.01 Å and 3.01 +- 0.01 Å. Independent claims are included for: (1) the preparation of (A); (2) crystalline modification II of pyroclostobin (A1) exhibiting at least four reflexes in a X-ray powder diffractogram at 25[deg]C, where the reflections (d) are 5.93 +- 0.01 Å, 5.82 +- 0.01 Å, 4.89 +- 0.01 Å, 4.78 +- 0.01 Å, 4.71 +- 0.01 Å, 3.97 +- 0.01 Å, 3.89 +- 0.01 Å, 3.77 +- 0.01 Å, 3.75 +- 0.01 Å, 3.57 +- 0.01 Å and 3.43 +- 0.01 Å; (3) the preparation of (A1); and (4) a plant protection agent, which comprises pyraclostrobin in the form of modification IV or in the form of modification II and carrier materials and/or additives. ACTIVITY : Fungicide. MECHANISM OF ACTION : None given.

    Formulation for seed treatment comprising polymeric stickers

    公开(公告)号:NZ548948A

    公开(公告)日:2009-09-25

    申请号:NZ54894805

    申请日:2005-02-12

    Applicant: BASF AG

    Abstract: Disclosed is a seed treatment formulation comprising (a) at least one pesticidal agent; and (b) acrylate copolymers, wherein the acrylate copolymers consist of (a') acrylic acid, methacrylic acid or itaconic acid or a combination of at least two monomers selected from the group consisting of acrylic acid, methacrylic acid or itaconic acid; and (b') monomers selected from the group consisting of alkyl (meth)acrylates such as methyl (meth)acrylate, ethyl (meth)acrylate, n-propyl (meth)acrylate, n-butyl meth)acrylate, tbutyl (meth)acrylate, lauryl (meth)acrylate, cyclohexyl (meth)acrylate 2-ethylhexyl (meth)acrylate, stearyl (meth)acrylate, dodecyl(meth)acrylate and (meth)acrylamides such as dimethy/(meth)acrylamide, diethyl(meth)acry/amide, isopropyl (meth)acrylamide, (meth)acryloyl morpholine, dimethylaminomethyl(meth)acrylamide, dimethylaminoethyl(meth)acrylamide, dimethylaminopropyl(meth)acrylamide, diethylaminomethyl(meth)acrylamide, diethylaminoethyl(meth)acrylamide, diethylaminopropyl(meth)acrylamide; and (c') monomers selected from the group consisting of 2-hydroxyethyl acrylate, 2-hydroxypropyl acrylate, 2-hydroxyethyl methacrylate, 2-hydroxypropyl methacrylate, glycidyl (meth)acrylate; and (d') monomers selected from the group consisting of styrene and styrene derivatives such as styrene, a-methyl styrene, o-methyl styrene, m-methyl styrene p-methyl styrene, p-t-butyl styrene, pchloromethyl styrene, p-styrenesulfonic acid and its sodium or potassium salt, o-methoxystyrene, m-methoxystyrene, pmethoxystyrene; and have either a glass transition temperature of -40°C to 5°C; or, if the acrylate copolymers have a core/shell structure a glass transition temperature of the inner core of -60°C to 5°C and of the outer shell of 20°C to 150°C, and wherein the amount of the acrylate copolymer is between 0.5 and 15% (w/w) on a solid content base.

Patent Agency Ranking